(2-Chloro-4-methoxyphenyl)methanamine hydrochloride, 95%, 250mg

3-Amino-N-methyl-2-pyrrolidinone, 97.0%, 100mg

(S)-4-ISOPROPYL-2-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 98%, 250mg

Methyl Tridecanoate>98.0%(GC)5mL

2-Chlorobenzo[d]oxazol-5-ol, 98%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 98%, 5g

Methyl 6-bromo-1H-indole-2-carboxylate, 95.0%, 25g

6-BROMO-1-METHYL-1H-IMIDAZO[4,5-B]PYRAZINE FORMIC ACID, 95.0%, 2g

Colonna capillare per GC ROTI®Cap-1, 25 m, 0.53 mm, 1.00 µm, 1 Pezzo(i)

6-Oxa-1-azaspiro[3.5]nonane, 95.0%, 500mg

2-(4-Boc-piperazinyl)-2-(2-chlorophenyl)acetic acid, 98%, 250mg

Benzenemethanol, 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 95%, 250mg

3-Amino-2-methyl-propionic acid hydrate, 97.0%, 10g